SVACF Insider Trading - SciVac Therapeutics Inc.

Saham Orang Dalam

3,290,496 shares

Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

N/A

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

N/A

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan SciVac Therapeutics Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam	Rata-rata Keuntungan (%)	Saham Dimiliki	Terbagi Disesuaikan

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di SVACF / SciVac Therapeutics Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Maksimal	Harga di Maksimal	Maksimal Keuntungan ($)	Maksimum Pengembalian (%)
2023-07-10	GILLIS STEVEN	609,090	1.6500	609,090	1.6500	1,004,998	9	1.5000	-91,363	-9.09
2021-12-03	Beattie Nell	8,200	2.4492	273	73.4760	20,083
2020-04-24	PERCEPTIVE ADVISORS LLC	9,090,909	1.1000	303,030	33.0000	10,000,000
2019-10-04	Diaz-Mitoma Francisco	40,000	0.5000	1,333	15.0000	20,000
2019-10-01	McNulty Christopher	12,000	0.4730	400	14.1900	5,676
2019-10-01	Beattie Nell	10,000	0.4822	333	14.4660	4,822
2019-09-30	Baxter Jeff	150,000	0.5030	5,000	15.0900	75,450
2019-09-30	Diaz-Mitoma Francisco	14,500	0.5000	483	15.0000	7,250
2019-09-23	PERCEPTIVE ADVISORS LLC	20,000,000	0.5000	666,667	15.0000	10,000,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

SVACF / SciVac Therapeutics Inc. Insider Trades

Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di SVACF / SciVac Therapeutics Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Menit	Harga di Menit	Kerugian Maksimal Dihindari ($)	Kerugian Maksimal Dihindari (%)
2023-04-06	PERCEPTIVE ADVISORS LLC	4,251,563	0.1100	141,719	3.3000	467,672	202	0.4960	-397,379	-84.97
2023-04-05	PERCEPTIVE ADVISORS LLC	1,832,563	0.1300	61,085	3.9000	238,233
2023-04-04	PERCEPTIVE ADVISORS LLC	4,810,623	0.1600	160,354	4.8000	769,700
2021-12-01	PERCEPTIVE ADVISORS LLC	2,707,463	3.3100	90,249	99.3000	8,961,703
2021-06-29	PERCEPTIVE ADVISORS LLC	500,709	3.8000	16,690	114.0000	1,902,694
2021-06-29	PERCEPTIVE ADVISORS LLC	145,548	3.8000	4,852	114.0000	553,082
2021-06-09	PERCEPTIVE ADVISORS LLC	1,102,179	4.0000	36,739	120.0000	4,408,716
2021-06-09	PERCEPTIVE ADVISORS LLC	320,388	4.0000	10,680	120.0000	1,281,552

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas Tanggal	Perdagangan Tanggal	Formulir	Orang Dalam	Ticker	Judul Keamanan	Kode	Langsung	Latihan Harga	Satuan Harga	Unit Diubah	Nilai Diubah (1 ribu)	Sisa Pilihan	Sisa Saham
2023-07-18	2023-07-10	4	GILLIS STEVEN See Footnotes	VBIV	Common Shares, no par value per share	P - Purchase	I		1.6500	609,090	1,005		1,043,292
2023-04-06	2023-04-06	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		0.1100	-4,251,563	-468		41,440,729
2023-04-06	2023-04-05	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		0.1300	-1,832,563	-238		45,691,816
2023-04-06	2023-04-04	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		0.1600	-4,810,623	-770		47,524,379
2022-01-31	2022-01-27	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		75,000		75,000
2022-01-31	2022-01-27	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		400,000		400,000
2022-01-31	2022-01-27	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		75,000		75,000
2022-01-31	2022-01-27	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		400,000		400,000
2022-01-31	2022-01-27	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		100,000		100,000
2022-01-31	2022-01-27	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		400,000		400,000
2022-01-31	2022-01-27	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		75,000		75,000
2022-01-31	2022-01-27	4	Braga Damian	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		75,000		75,000
2022-01-31	2022-01-27	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		400,000		400,000
2022-01-31	2022-01-27	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		800,000		800,000
2022-01-31	2022-01-27	4	Bain Linda	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		75,000		75,000
2022-01-31	2022-01-27	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.53		400,000		400,000
2021-12-06	2021-12-03	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		2.4492	8,200	20		68,200
2021-12-03	2021-12-01	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		3.3100	-2,707,463	-8,962		52,334,993
2021-07-07	2021-07-01	4	Bain Linda	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.43		250,000		250,000
2021-06-30	2021-06-29	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		3.8000	-145,548	-553		0
2021-06-30	2021-06-29	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		3.8000	-500,709	-1,903		0
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Warrant (right to buy)	X - Other	I	2.75		-465,936		0
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Warrant (right to buy)	X - Other	I	2.75		-1,602,888		0
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		4.0000	-320,388	-1,282		145,548
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		4.0000	-1,102,179	-4,409		500,709
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	X - Other	I		2.7500	465,936	1,281		465,936
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	X - Other	I		2.7500	1,602,888	4,408		1,602,888
2021-02-01	2021-01-27	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		75,000		75,000
2021-02-01	2021-01-27	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.14		500,000		500,000
2021-01-29	2021-01-27	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		75,000		75,000
2021-01-29	2021-01-27	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.14		500,000		500,000
2021-01-29	2021-01-27	4	Braga Damian	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		75,000		75,000
2021-01-29	2021-01-27	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		500,000		500,000
2021-01-29	2021-01-27	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		75,000		75,000
2021-01-29	2021-01-27	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		500,000		500,000
2021-01-29	2021-01-27	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		500,000		500,000
2021-01-29	2021-01-27	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		100,000		100,000
2021-01-29	2021-01-27	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.15		1,000,000		1,000,000
2020-07-02	2020-07-01	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2.94		425,200		425,200
2020-07-02	2020-07-01	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2.99		167,150		167,150
2020-07-02	2020-07-01	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2.99		167,150		167,150
2020-07-02	2020-07-01	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2.94		170,100		170,100
2020-07-02	2020-07-01	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2.94		170,100		170,100
2020-07-02	2020-07-01	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2.94		170,100		170,100
2020-04-28	2020-04-24	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		1.1000	9,090,909	10,000		55,042,456
2020-03-24	2020-03-24	4	Braga Damian	VBIV	Option (Right to Buy Common Shares)	A - Award	D	0.81		250,000		250,000
2020-01-24	2020-01-22	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		250,000		250,000
2020-01-24	2020-01-22	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		350,000		350,000
2020-01-24	2020-01-22	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		350,000		350,000
2020-01-24	2020-01-22	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		350,000		350,000
2020-01-24	2020-01-22	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		250,000		250,000
2020-01-24	2020-01-22	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.66		350,000		350,000
2020-01-24	2020-01-22	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		350,000		350,000
2020-01-24	2020-01-22	4	Mazaltov Avi	VBIV	Restricted Stock Units	A - Award	D			50,000		50,000
2020-01-24	2020-01-22	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		250,000		250,000
2020-01-24	2020-01-22	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.46		500,000		500,000
2019-10-07	2019-10-04	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		0.5000	40,000	20		117,500
2019-10-07	2019-09-30	4	Diaz-Mitoma Francisco By wife	VBIV	Common Shares, no par value per share	P - Purchase	I		0.5000	14,500	7		14,500
2019-10-01	2019-10-01	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		0.4822	10,000	5		60,000
2019-10-01	2019-10-01	4	McNulty Christopher	VBIV	Common Shares, no par value per share	P - Purchase	D		0.4730	12,000	6		37,000
2019-09-30	2019-09-30	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		0.5030	150,000	75		608,255
2019-09-24	2019-09-23	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		0.5000	20,000,000	10,000		45,951,556
2019-07-01	2019-06-27	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		1.0700	8,000	9		77,500
2019-06-20	2019-06-20	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		0.8900	42,000	37		69,500
2019-06-20	2019-06-20	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		0.7800	10,000	8		27,500
2019-06-20	2019-06-18	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		0.6500	1,000,000	650		25,951,556
2019-06-19	2019-06-19	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		0.7315	144,000	105		458,255
2019-06-19	2019-06-19	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		0.7357	8,000	6		50,000
2019-06-18	2019-06-14	4	GILLIS STEVEN	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18,750		0
2019-06-18	2019-06-14	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D			18,750			84,416
2019-06-18	2019-06-14	4	Baxter Jeff	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-31,250		0
2019-06-18	2019-06-14	4	Baxter Jeff	VBIV	Common Shares, no par value per share	M - Exercise	D			31,250			314,255
2019-06-18	2019-06-14	4	Beattie Nell	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-6,250		0
2019-06-18	2019-06-14	4	Beattie Nell	VBIV	Common Shares, no par value per share	M - Exercise	D			6,250			42,000
2019-06-18	2019-06-14	4	DeWilde Michel	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		0
2019-06-18	2019-06-14	4	DeWilde Michel	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			50,000
2019-06-18	2019-06-14	4	Anderson David Evander	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-21,875		0
2019-06-18	2019-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	M - Exercise	D			21,875			148,209
2019-06-18	2019-06-17	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		0.6180	1,000,000	618		24,951,556
2019-04-24	2019-04-18	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.97		200,000		200,000
2019-02-04	2019-01-31	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		300,000		300,000
2019-02-04	2019-01-31	4	Beattie Nell	VBIV	Common Shares, no par value per share	A - Award	D			15,000			35,750
2019-02-04	2019-01-31	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		300,000		300,000
2019-02-04	2019-01-31	4	Anderson David Evander	VBIV	Common Shares, no par value per share	A - Award	D			25,000			126,334
2019-02-04	2019-01-31	4	Mazaltov Avi	VBIV	Common Share	A - Award	D			90,000			196,000
2019-02-04	2019-01-31	4	Requadt Scott	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		200,000		200,000
2019-02-04	2019-01-31	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		300,000		300,000
2019-02-04	2019-01-31	4	McNulty Christopher	VBIV	Common Shares, no par value per share	A - Award	D			25,000			25,000
2019-02-04	2019-01-31	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		200,000		200,000
2019-02-04	2019-01-31	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		450,000		450,000
2019-02-04	2019-01-31	4	Baxter Jeff	VBIV	Common Shares, no par value per share	A - Award	D			50,000			283,005
2019-02-04	2019-01-31	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.64		300,000		300,000
2019-02-04	2019-01-31	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		300,000		300,000
2019-02-04	2019-01-31	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.67		300,000		300,000
2019-02-04	2019-01-31	4	Kariv Tomer	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.64		200,000		200,000
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax Late Stage Fund L.P.	VBIV	Common Stock	P - Purchase	I		1.4000	185,714	260		185,714
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax (China) IV Limited Partnership	VBIV	Common Stock	P - Purchase	I		1.4000	331,429	464		943,451
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Stock	P - Purchase	I		1.4000	298,431	418		849,520
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax (Israel) IV Limited Partnership	VBIV	Common Stock	P - Purchase	I		1.4000	612,997	858		1,744,969
2018-12-17	2018-12-13	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		1.4000	14,285,714	20,000		23,631,439
2018-09-21	2018-09-19	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1.83		250,000		250,000
2018-08-07	2018-08-06	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		1.9268	8,100	16		233,005
2018-08-06	2018-08-03	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		2.1000	6,000	13		17,500
2018-08-06	2018-08-02	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		2.2000	3,000	7		11,500
2018-08-06	2018-08-03	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2.0082	13,500	27		224,905
2018-08-03	2018-08-03	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		2.0057	2,000	4		20,750
2018-08-01	2018-07-31	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2.2760	16,800	38		211,405
2018-07-03	2018-06-14	4/A	Anderson David Evander	VBIV	Common Shares, no par value per share	F - Taxes	D		3.7600	-9,281	-35		101,334
2018-06-29	2018-01-23	4/A	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		0		0
2018-06-29	2018-01-23	4/A	Mazaltov Avi	VBIV	Common Share	A - Award	D			100,000			106,000
2018-06-25	2018-06-14	4	GILLIS STEVEN	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18,750		18,750
2018-06-25	2018-06-14	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D			18,750			65,666
2018-06-20	2018-06-14	4	DeWilde Michel	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		12,500
2018-06-20	2018-06-14	4	DeWilde Michel	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			37,500
2018-06-18	2018-06-14	4	Requadt Scott	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		12,500
2018-06-18	2018-06-14	4	Requadt Scott	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			37,500
2018-06-18	2018-06-14	4	Rubin Steven D	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18,750		18,750
2018-06-18	2018-06-14	4	Rubin Steven D	VBIV	Common Shares, no par value per share	M - Exercise	D			18,750			56,250
2018-06-18	2018-06-14	4	Baxter Jeff	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-31,250		31,250
2018-06-18	2018-06-14	4	Baxter Jeff	VBIV	Common Shares, no par value per share	M - Exercise	D			31,250			194,605
2018-06-18	2018-06-14	4	Beattie Nell	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-6,250		6,250
2018-06-18	2018-06-14	4	Beattie Nell	VBIV	Common Shares, no par value per share	M - Exercise	D			6,250			18,750
2018-06-18	2018-06-14	4	Anderson David Evander	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-21,875		21,875
2018-06-18	2018-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	F - Taxes	D		3.7600	-9,306	-35		101,309
2018-06-18	2018-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	M - Exercise	D			21,875			110,615
2018-06-18	2018-06-14	4	Logal Adam	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		12,500
2018-06-18	2018-06-14	4	Logal Adam	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			37,500
2018-05-25	2018-05-24	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2.9900	11,000	33		163,355
2018-05-14	2018-05-11	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2.9100	7,100	21		152,355
2018-05-14	2018-05-11	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value	P - Purchase	D		3.1300	4,500	14		268,839
2018-05-14	2018-05-11	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value	P - Purchase	I		2.9800	5,500	16		8,500
2018-02-06	2018-01-23	4	Kartsaklis Athena	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.26		75,000		75,000
2018-01-30		3	Mazaltov Avi	VBIV	Common Shares, no par value per share		D						12,000
2018-01-30		3	Mazaltov Avi	VBIV	Common Shares, no par value per share		D						12,000
2018-01-30	2018-01-23	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		100,000		100,000
2018-01-29		3	Kariv Tomer By Pontifax (China) IV Limited Partnership	VBIV	Common Stock		I						2,907,105
2018-01-29		3	Kariv Tomer By Pontifax (Israel) IV Limited Partnership	VBIV	Common Stock		I						3,427,055
2018-01-29		3	Kariv Tomer By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Stock		I						2,846,172
2018-01-29		3	Kariv Tomer By Pontifax (China) IV Limited Partnership	VBIV	Common Stock		I						2,907,105
2018-01-29		3	Kariv Tomer By Pontifax (Israel) IV Limited Partnership	VBIV	Common Stock		I						3,427,055
2018-01-29		3	Kariv Tomer By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Stock		I						2,846,172
2018-01-29	2018-01-23	4	Kariv Tomer	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		75,000		75,000
2018-01-26	2018-01-23	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		75,000		75,000
2018-01-25	2018-01-23	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		100,000		100,000
2018-01-25	2018-01-23	4	Logal Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		75,000		75,000
2018-01-25	2018-01-23	4	Rubin Steven D	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		75,000		75,000
2018-01-25	2018-01-23	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.26		100,000		100,000
2018-01-25	2018-01-23	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		100,000		100,000
2018-01-25	2018-01-23	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		100,000		100,000
2018-01-25	2018-01-23	4	Buckley T. Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		75,000		75,000
2018-01-25	2018-01-23	4	Requadt Scott	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		75,000		75,000
2018-01-25	2018-01-23	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4.19		150,000		150,000
2017-12-13	2017-12-12	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3.8800	4,609	18		145,255
2017-12-13	2017-12-12	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3.8900	5,391	21		140,646
2017-11-29	2017-11-28	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		4.7500	15,000	71		135,255
2017-11-09		3	Opko Health, Inc.	VBIV	Common Stock		D						12,046,028
2017-11-09		3	Opko Health, Inc.	VBIV	Common Stock		D						12,046,028
2017-11-01	2017-10-30	4	Opko Health, Inc.	VBIV	Common Stock	P - Purchase	D		3.0500	655,738	2,000		6,678,752
2017-10-31		3	Nussbaum Ran By Pontifax (Israel) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						3,427,055
2017-10-31		3	Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2,846,172
2017-10-31		3	Nussbaum Ran By Pontifax (China) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2,907,105
2017-10-31		3	Nussbaum Ran By Pontifax (Israel) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						3,427,055
2017-10-31		3	Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2,846,172
2017-10-31		3	Nussbaum Ran By Pontifax (China) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2,907,105
2017-10-31	2017-10-30	4	CHAWLA SAM	VBIV	Common Shares, no par value per share	P - Purchase	I		3.0500	3,100,000	9,455		9,345,725
2017-10-31	2017-10-30	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	P - Purchase	I		3.0500	300,000	915		3,026,057
2017-10-30	2017-10-26	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		3.0500	3,100,000	9,455		9,345,725
2017-08-22	2017-08-21	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		3.1700	3,000	10		3,000
2017-08-22	2017-08-21	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3.2200	10,000	32		120,255
2017-08-14	2017-08-10	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3.2800	10,000	33		110,255
2017-06-23	2017-06-22	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	A - Award	D			12,500			264,339
2017-06-16	2017-06-14	4	DeWilde Michel	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		25,000
2017-06-16	2017-06-14	4	DeWilde Michel	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			25,000
2017-06-16	2017-06-14	4	Buckley T. Adam	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-4,687		9,374
2017-06-16	2017-06-14	4	Buckley T. Adam	VBIV	Common Shares, no par value per share	M - Exercise	D			4,687			44,063
2017-06-16	2017-06-14	4	Rubin Steven D	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18,750		37,500
2017-06-16	2017-06-14	4	Rubin Steven D	VBIV	Common Shares, no par value per share	M - Exercise	D			18,750			37,500
2017-06-16	2017-06-14	4	GILLIS STEVEN	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18,750		37,500
2017-06-16	2017-06-14	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D			18,750			46,916
2017-06-16	2017-06-14	4	CHAWLA SAM	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		25,000
2017-06-16	2017-06-14	4	CHAWLA SAM	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			25,000
2017-06-16	2017-06-14	4	Requadt Scott	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		25,000
2017-06-16	2017-06-14	4	Requadt Scott	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			25,000
2017-06-16	2017-06-14	4	Anderson David Evander	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-21,875		43,750
2017-06-16	2017-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	M - Exercise	D			21,875			88,740
2017-06-16	2017-06-14	4	Baxter Jeff	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-31,250		62,500
2017-06-16	2017-06-14	4	Baxter Jeff	VBIV	Common Shares, no par value per share	M - Exercise	D			31,250			100,255
2017-06-16	2017-06-14	4	Beattie Nell	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-6,250		12,500
2017-06-16	2017-06-14	4	Beattie Nell	VBIV	Common Shares, no par value per share	M - Exercise	D			6,250			12,500
2017-06-16	2017-06-14	4	Logal Adam	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12,500		25,000
2017-06-16	2017-06-14	4	Logal Adam	VBIV	Common Shares, no par value per share	M - Exercise	D			12,500			25,000
2017-04-27		3	Baxter Jeff	VBIV	Common Shares, no par value per share		D						138,010
2017-04-27		3	Baxter Jeff	VBIV	Common Shares, no par value per share		D						138,010
2017-04-27		3	DeWilde Michel	VBIV	Common Shares, no par value per share		D						25,000
2017-04-27		3	DeWilde Michel	VBIV	Common Shares, no par value per share		D						25,000
2017-04-27	2017-04-18	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		20,000		20,000
2017-04-27	2017-04-17	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		12,500		12,500
2017-04-04		3	Anderson David Evander	VBIV	Common Shares, no par value per share		D						133,730
2017-04-04		3	Anderson David Evander	VBIV	Common Shares, no par value per share		D						133,730
2017-04-04		3	Beattie Nell	VBIV	Common Shares, no par value per share		D						12,500
2017-04-04		3	Beattie Nell	VBIV	Common Shares, no par value per share		D						12,500
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		D						2,716,042
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		I						5,394,584
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		D						2,716,042
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		I						5,394,584
2017-04-04	2017-04-03	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		20,000		20,000
2017-04-04	2017-03-31	4	Requadt Scott	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		12,500		12,500
2017-04-04	2017-03-31	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		20,000		20,000
2017-03-31		3	Logal Adam	VBIV	Common Shares, no par value per share		D						25,000
2017-03-31		3	Logal Adam	VBIV	Common Shares, no par value per share		D						25,000
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		D						6,590,843
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		I						13,144,186
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		I						13,144,186
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		D						6,590,843
2017-03-31		3	Nascimento Egidio	VBIV	Common Shares, no par value per share		D						5,936
2017-03-31		3	Nascimento Egidio	VBIV	Common Shares, no par value per share		D						5,936
2017-03-31		3	Buckley T. Adam	VBIV	Common Shares, no par value per share		D						78,752
2017-03-31		3	Buckley T. Adam	VBIV	Common Shares, no par value per share		D						78,752
2017-03-31		3	Rubin Steven D	VBIV	Common Shares, no par value per share		D						37,500
2017-03-31		3	Rubin Steven D	VBIV	Common Shares, no par value per share		D						37,500
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		I						5,473,903
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		D						2,769,635
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		I						5,473,903
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		D						2,769,635
2017-03-31		3	Eckenswiller Catherine	VBIV	Common Shares, no par value per share		D						0
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		I						278,147
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		I						278,147
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		D						498,082
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		D						498,082
2017-03-31	2017-03-29	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.45		20,000		20,000
2017-03-31	2017-03-29	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	A - Award	D			12,500			251,839
2017-03-31	2017-03-30	4	Rubin Steven D	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		12,500		12,500
2017-03-31	2017-03-29	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		15,000		15,000
2017-03-31	2017-01-17	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	M - Exercise	D	2.50	2.5000	-6,377	-16	0
2017-03-31	2017-01-17	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D		2.5000	6,377	16		28,166
2017-03-31	2017-03-31	4	Eckenswiller Catherine	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.45		3,000		3,000
2017-03-31	2017-03-30	4	Nascimento Egidio	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.45		20,000		20,000
2017-03-31	2017-03-30	4	Buckley T. Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		20,000		20,000
2017-03-31	2017-03-30	4	Logal Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		12,500		12,500
2017-03-31	2017-03-30	4	CHAWLA SAM	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3.79		12,500		12,500

Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.

Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.

Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)

Konversi turunan

Penjualan atau pengalihan sekuritas kembali ke perusahaan.

Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.

Pemberian sekuritas oleh atau kepada orang dalam.

Swap ekuitas dan transaksi lindung nilai serupa

Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)

Transaksi yang dilaporkan secara sukarela pada Formulir 4.

Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)

SVACF / SciVac Therapeutics Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5